We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

92 hedge funds and large institutions have $108M invested in Seelos Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 15

53% more funds holding

Funds holding: 60 → 92 (+32)

39% more call options, than puts

Call options by funds: $1.97M | Put options by funds: $1.42M

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

14% less capital invested

Capital invested by funds: $125M → $108M (-$17.1M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
92
Holders Change
+32
Holders Change %
+53.33%
% of All Funds
1.6%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
47
Increased
22
Reduced
16
Closed
15
Calls
$1.97M
Puts
$1.42M
Net Calls
+$548K
Net Calls Change
+$1.38M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.7M
2
WP
Woodline Partners
California
+$9.99M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$8.04M
4
JGC
J. Goldman & Co
New York
+$7.85M
5
Two Sigma Investments
Two Sigma Investments
New York
+$7.72M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$14.7M
2
MWNA
Marshall Wace North America
New York
-$7.22M
3
ECM
Endurant Capital Management
California
-$3.05M
4
Marshall Wace
Marshall Wace
United Kingdom
-$3.04M
5
ACM
Asymmetry Capital Management
California
-$2.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
$125K -$329K -20 -63%
AllianceBernstein
52
AllianceBernstein
Tennessee
$109K +$181K +11 New
BFM
53
Boothbay Fund Management
New York
$88K -$214K -13 -59%
Simplex Trading
54
Simplex Trading
Illinois
$88K +$16.4K +1 +13%
Principal Financial Group
55
Principal Financial Group
Iowa
$79K +$131K +8 New
WP
56
WealthPLAN Partners
Nebraska
$78K +$65.7K +4 +80%
PPA
57
Parametric Portfolio Associates
Washington
$78K +$131K +8 New
VOYA Investment Management
58
VOYA Investment Management
Georgia
$78K +$131K +8 New
CS
59
Credit Suisse
Switzerland
$77K +$131K +8 New
JP Morgan Chase
60
JP Morgan Chase
New York
$77K +$131K +8 New
Group One Trading
61
Group One Trading
Illinois
$75K +$115K +7 New
AMC
62
Asset Management Corp
Illinois
$71K -$49.3K -3 -30%
HighTower Advisors
63
HighTower Advisors
Illinois
$65K – – –
HCM
64
Hollencrest Capital Management
California
$63K – – –
Truist Financial
65
Truist Financial
North Carolina
$58K +$98.6K +6 New
First Manhattan
66
First Manhattan
New York
$57K +$49.3K +3 +100%
Walleye Trading
67
Walleye Trading
New York
$57K +$98.6K +6 New
Osaic Holdings
68
Osaic Holdings
Arizona
$56K +$65.7K +4 +200%
Invesco
69
Invesco
Georgia
$54K -$14.7M -897 -99%
BCM
70
Bayesian Capital Management
New York
$52K +$82.2K +5 New
ProShare Advisors
71
ProShare Advisors
Maryland
$52K +$82.2K +5 New
SG Americas Securities
72
SG Americas Securities
New York
$52K +$82.2K +5 New
Commonwealth Equity Services
73
Commonwealth Equity Services
Massachusetts
$51K – – –
T. Rowe Price Associates
74
T. Rowe Price Associates
Maryland
$47K +$82.2K +5 New
SO
75
STRS Ohio
Ohio
$46K +$82.2K +5 New
1 2
3
4 5

SEEL Hedge Fund Activity: Q2 2021 in Review

92 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q2 2021, worth a combined $108M — down 14% from $125M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new SEEL positions and 15 closed out — a net gain of 32 holders — while 22 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $17.7M. The largest seller was Invesco, cutting an estimated $14.7M.

  • 92 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q2 2021, up from 60 in Q1 2021.
  • Funds reported $108M of Seelos Therapeutics, Inc. Common Stock stock for Q2 2021, down 14% quarter-over-quarter.
  • 47 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q2 2021 and 15 closed out, a net change of +32 holders.
  • The largest Seelos Therapeutics, Inc. Common Stock buyer in Q2 2021 was BlackRock, an estimated $17.7M added.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q2 2021 was Invesco, an estimated $14.7M sold.

Based on aggregated 13F filings for Q2 2021.